VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VSEE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VSEEVSee Health, Inc.
$0.11$2M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

VSEE logoVSee Health, Inc.(VSEE)Earnings, Financials & Key Ratios

VSEE•NASDAQ
$0.11
Price updated Jul 7, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryVirtual Care and Digital Programs
AboutVSee Health, Inc. provides telehealth care solutions. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. Its telehealth platform provides a set of building blocks to solve needs of clients. VSee Health, Inc. is headquartered in Newton, Massachusetts.Show more
  • Revenue$15M+40.3%
  • EBITDA-$7M+88.6%
  • Net Income-$15M+74.5%
  • EPS (Diluted)-0.73+87.1%
  • Gross Margin50.32%-26.9%
  • EBITDA Margin-47.4%+91.9%
  • Operating Margin-65.55%+89.0%
  • Net Margin-100.65%+81.8%
  • ROE-541.52%

VSEE Price & Volume

VSee Health, Inc. (VSEE) stock price & volume — 10-year historical chart

Loading chart...

Persistent Operational Losses Challenge VSee Health Viability

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Liquidity and solvency constraints

Key Thesis Takeaways

  • VSee Health faces significant fundamental headwinds characterized by volatile revenue cycles and a deteriorating gross margin profile that compressed from 74.2% in 2024Q1 to 37.9% in 2026Q1.
  • The company's reliance on external capital is underscored by a persistent inability to generate positive free cash flow, which reached an outflow of $2.5 million in 2026Q1 alone.
  • Investors should remain cautious as the current liquidity position, evidenced by a 0.41 current ratio, suggests limited operational runway to support the company's ongoing, loss-making growth strategy.

Verdict Logic

the company's fundamental instability is highlighted by a net margin of -82.3% in 2026Q1 and a persistent, unsustainable operating burn rate.

VSEE Growth Metrics

VSee Health, Inc. (VSEE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years16.52%
3 Years31.85%
TTM18.05%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM78.34%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM86.87%

Return on Capital

10 Years-1306.51%
5 Years-1649.6%
3 Years-3297.98%
Last Year-268.03%

VSEE Recent Earnings

VSee Health, Inc. (VSEE) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 2/12 qtrs (40%)●Beat Revenue 1/12 qtrs (20%)
Q2 2026Latest
May 15, 2026
Metric
Actual
Est
EPS
$0.05+54.5%
$0.11
Rev
$3M-34.2%
$5M
Q2 2026
Mar 31, 2026
Metric
Actual
Est
EPS
$0.31-287.5%
$0.08
Rev
$4M-10.8%
$4M
Q4 2025
Nov 14, 2025
Metric
Actual
Est
EPS
$0.02+75.0%
$0.08
Rev
$4M-5.2%
$4M
Q4 2025
Oct 15, 2025
Metric
Actual
Est
EPS
$0.14-16.7%
$0.12
Rev
$3M-13.1%
$4M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 15, 2026
$0.05vs $0.11+54.5%
$3Mvs $5M-34.2%
Q2 2026Mar 31, 2026
$0.31vs $0.08-287.5%
$4Mvs $4M-10.8%
Q4 2025Nov 14, 2025
$0.02vs $0.08+75.0%
$4Mvs $4M-5.2%
Q4 2025Oct 15, 2025
$0.14vs $0.12-16.7%
$3Mvs $4M-13.1%
Based on last 12 quarters of dataView full earnings history →

Latest VSEE News

Recent stock market news and headlines for VSee Health, Inc. (VSEE)

Accesswire·Jun 25, 2026
VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations

Key Driver for its Enterprise Telehealth Revenue Acceleration HOUSTON, TX / ACCESS Newswire / June 25, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, is pleased to announce that its hospital footprint has grown to 58 locations, up from just 3 in approximately two tears. This dramatic ramp of 20-fold over the past two years, has led to a significant +80% growth in revenue in 2025 to $11.4 million.

Accesswire·Jun 22, 2026
VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale

Refocus on Telehealth and Digital Health Solutions That Provided 80% Revenue Growth in 2025 HOUSTON, TX / ACCESS Newswire / June 22, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solution, is pleased to provide an update on its business operations and financial success following its strategic sale of VSee Lab on May 31, 2026. Pro-forma financials from enhanced focus on iDoc telehealth platform and enterprise healthcare solutions: +60% revenue growth to $8 million in 2025 +70% revenue growth to $2.5 million in Q1 2026 Approximate reduction of $6.0 million in annual operating expenses Several large IDN (Integrated Health Network) multi-year contracts that were signed throughout 2025 are continuing to roll out, build revenue and add more telehealth services.

Peers Comparison

Key metrics vs top competitors for VSee Health, Inc. (VSEE)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
VSEE logoVSEEVSee Health, Inc.Current
$0.11$1.79M-0.1540.27%-100.65%-541.52%—
TDOC logoTDOCTeladoc Health, Inc.
$9.10$1.64B-7.98-1.54%-6.81%-12.37%—
AMWL logoAMWLAmerican Well Corporation
$8.99$150.21M-1.51-1.98%-48.16%-33.48%—
OPRX logoOPRXOptimizeRx Corporation
$6.29$118.03M23.3018.78%6.37%5.47%—
TALK logoTALKTalkspace, Inc.
$5.20$871.07M130.0022%0.49%1.03%—
DOCS logoDOCSDoximity, Inc.
$22.74$4.25B23.2013.05%30.4%19.36%—

Compare VSEE vs Peers

VSee Health, Inc. (VSEE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs TDOC

Most directly comparable listed peer for VSEE.

Scale Benchmark

vs WELL

Larger-name benchmark to compare VSEE against a more recognizable public peer.

Peer Set

Compare Top 5

vs TDOC, AMWL, OPRX, TALK

VSEE SEC Filings & Documents

VSee Health, Inc. (VSEE) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Jun 11, 2026·SEC

Material company update

Jun 11, 2026·SEC

Material company update

Jun 5, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 31, 2026·SEC

FY 2025

Aug 28, 2025·SEC

10-Q Quarterly Reports

5
FY 2026

May 15, 2026·SEC

FY 2025

Nov 14, 2025·SEC

FY 2025

Oct 15, 2025·SEC

Get notified when VSEE posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

VSEE Frequently Asked Questions

VSee Health, Inc. (VSEE) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is VSee Health, Inc.'s revenue?

VSee Health, Inc. (VSEE) reported $14.5M in revenue for fiscal year 2025. This represents a 112% increase from $6.8M in 2020.

How fast is VSee Health, Inc. growing?

VSee Health, Inc. (VSEE) grew revenue by 40.3% over the past year. This is strong growth.

Is VSEE profitable?

VSee Health, Inc. (VSEE) reported a net loss of $13.4M for fiscal year 2025.

Dividend & Returns
What is VSEE's return on equity?

VSee Health, Inc. (VSEE) has a return on equity (ROE) of -541.5%. Negative ROE indicates the company is unprofitable.

What is VSee Health, Inc.'s free cash flow?

VSee Health, Inc. (VSEE) had negative free cash flow of $5.5M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in VSEE back in 2020?

Total return calculator · dividends reinvested · 6+ years of data

See returns →